GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumito AB (NGM:LUMITO) » Definitions » Beta

Lumito AB (NGM:LUMITO) Beta : N/A (As of Sep. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lumito AB Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-09-24), Lumito AB's Beta is Not available.


Lumito AB Beta Historical Data

The historical data trend for Lumito AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumito AB Beta Chart

Lumito AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial - - - - -

Lumito AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lumito AB's Beta

For the Diagnostics & Research subindustry, Lumito AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumito AB's Beta Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumito AB's Beta distribution charts can be found below:

* The bar in red indicates where Lumito AB's Beta falls into.



Lumito AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Lumito AB  (NGM:LUMITO) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Lumito AB Beta Related Terms

Thank you for viewing the detailed overview of Lumito AB's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumito AB Business Description

Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, SE-226 43
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed a development and business plan for the development of an instrument for digital pathology that improves the quality of tissue sample mapping.

Lumito AB Headlines

No Headlines